Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 4,288
Operating expenses:
Research and development	28,766	25,745	101,211	61,451
General and administrative	13,106	8,279	34,929	25,035
Net gain on lease termination	0	0	(3,433)	0
Total operating expenses	41,872	34,024	132,707	86,486
Loss from operations	(41,872)	(34,024)	(132,707)	(82,198)
Other income (expense):
Change in fair value of warrant liability	0	(292)	0	(463)
Change in fair value of term loan	(1,087)	(1,534)	(4,078)	(4,525)
Interest income	3,903	3,169	8,814	6,354
Interest expense	(4)	(15)	(19)	(51)
Other expense	(68)	(37)	(187)	(261)
Total other income, net	2,744	1,291	4,530	1,054
Net loss	$ (39,128)	$ (32,733)	$ (128,177)	$ (81,144)
Net loss per common share, basic	$ (0.1)	$ (0.09)	$ (0.34)	$ (0.26)
Net loss per common share, diluted	$ (0.1)	$ (0.09)	$ (0.34)	$ (0.26)
Weighted average common shares outstanding, basic	406,106,872	353,309,524	380,739,173	307,175,982
Weighted average common shares outstanding, diluted	406,106,872	353,309,524	380,739,173	307,175,982